Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Receptor levels in breast cancer.

G B Nardelli1, V Lamaina, S Marson

  • 1Institute of Obstetrics and Gynaecology, University of Padua, Italy.

European Journal of Gynaecological Oncology
|January 1, 1988
PubMed
Summary

Estrogen receptor (ER) and progesterone receptor (PgR) are key breast cancer markers. PgR presence indicates estrogenic action, while ER+ levels influence prognosis and PgR+ levels predict treatment response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pituitary block with gonadotrophin-releasing hormone antagonist during intrauterine insemination cycles: a systematic review and meta-analysis of randomised controlled trials.

BJOG : an international journal of obstetrics and gynaecology·2018
Same author

Innovative clinical pathways for obese pregnant women: design and feasibility of the Padua project (North-Eastern Italy).

Journal of endocrinological investigation·2017
Same author

Four cases of fetal intra-abdominal umbilical vein varix: a single centre's approach to management.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2013
Same author

The trend of VEGF-A and PlGF in pregnant patients: a perspective case-control study on 214 women.

Clinical and experimental obstetrics & gynecology·2012
Same author

Correlation between fetal movement revealed in actography and fetal-neonatal well-being: observational study on 3,805 pregnancies followed in a Northern Italy tertiary care hospital.

Clinical and experimental obstetrics & gynecology·2012
Same author

Laparoscopic management of gynaecological cancer in pregnancy.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2010

Area of Science:

  • Oncology
  • Biomarker Research
  • Breast Cancer Studies

Background:

  • Estrogen receptor (ER) and progesterone receptor (PgR) are critical biomarkers in breast cancer management.
  • Understanding the interplay between ER and PgR status is essential for accurate prognostication and treatment selection.

Purpose of the Study:

  • To investigate the relative importance and interrelationship of ER and PgR as markers in a cohort of 352 breast cancer patients.
  • To elucidate the prognostic and predictive significance of individual and combined ER/PgR positivity.

Main Methods:

  • Analysis of ER and PgR status in 352 breast cancer samples.
  • Statistical evaluation of the association between ER and PgR positivity.
  • Correlation of ER/PgR status with prognostic and predictive outcomes.

Main Results:

  • ER positivity does not necessitate PgR positivity, but PgR positivity implies estrogenic activity.
  • PgR positivity is frequently observed in ER-negative detectable cases (91.42%).
  • ER+ levels correlate with prognostic value, while PgR+ levels correlate with predictive value.

Conclusions:

  • The distinct roles of ER and PgR in breast cancer necessitate careful evaluation of their individual and combined status.
  • ER status is primarily linked to prognosis, whereas PgR status is more predictive of treatment response.
  • Further research into biomarker interactions can refine breast cancer treatment strategies.

Related Experiment Videos